Central Finland Hospital District Central Finland Hospital Nova
- Address
- lock Available on a paid plan
Neoplasm Research at Central Finland Hospital District Central Finland Hospital Nova
This site supports clinical research in cancer care, with studies focused on breast cancer, prostate cancer, and colorectal cancer. The trials aim to improve treatment effectiveness, slow disease progression, and better understand outcomes for people with advanced or high-risk disease.
- Testing new approaches to help delay progression in prostate cancer
- Evaluating added treatment options for early-stage, high-risk breast cancer
- Studying resectability, postoperative outcomes, and survival in metastatic colorectal cancer
This work reflects a strong focus on both treatment improvement and real-world cancer outcomes in Jyvaskyla.
Emergency and Acute Care Diagnostics
Clinical trials here also examine diagnostic techniques for urgent conditions, especially in patients with acute abdomen and reduced kidney function. The research is designed to improve the safety and accuracy of imaging choices in emergency care.
- Comparing imaging strategies to improve diagnosis in acute abdominal pain
- Assessing safer diagnostic options for patients with impaired renal function
- Supporting better decision-making in urgent gastrointestinal evaluation
The emphasis is on improving diagnostic quality while reducing risk for vulnerable patients.
Surgical and Thrombosis Prevention Studies
The site conducts research in health care quality and therapeutics related to surgery, with trials addressing venous thromboembolism prevention. These studies look at how to balance protection from clots with bleeding risk in patients undergoing surgery.
- Evaluating clot-prevention strategies in surgical patients
- Studying the benefits and risks of anticoagulant use alongside standard care
- Improving treatment decisions for patients at uncertain risk of VTE
This research supports safer perioperative care and more individualized prevention strategies.
Digestive System and Appendicitis Research
Another key area is digestive system disease, especially uncomplicated acute appendicitis. The trials aim to compare treatment approaches and strengthen evidence for effective, less invasive care.
- Comparing antibiotic-based treatment strategies for acute appendicitis
- Assessing which approach best supports recovery in appendiceal inflammation
- Improving treatment choices for patients with confirmed appendicitis
This line of research helps clarify how to manage common emergency abdominal conditions more effectively.
Nervous System and Pediatric Prevention Studies
The trial portfolio includes work in nervous system diseases, with a focus on preventing infantile spasms in high-risk infants. These studies explore early intervention for children with conditions that increase the chance of severe seizure disorders.
- Investigating prevention of infantile spasm syndrome in high-risk infants
- Studying early treatment for children with tuberous sclerosis or major brain injury
- Supporting better outcomes in pediatric neurology through preventive care
The goal is to reduce the risk of serious neurological complications during infancy.
Musculoskeletal and Connective Tissue Research
Research at Central Finland Hospital Nova also covers musculoskeletal and skin and connective tissue conditions, particularly Dupuytren's contracture. The studies compare treatment strategies to determine which options work best and offer good value for patients.
- Comparing treatment approaches for Dupuytren's contracture
- Evaluating effectiveness and long-term outcomes in hand contracture care
- Supporting better treatment selection for connective tissue disorders
This research helps refine care for a condition that can limit hand function and daily activity.
Critical Care Research
The site participates in intensive care studies involving adults admitted with acute critical illness. These trials examine commonly used treatments to better understand which approaches improve outcomes in the ICU.
- Assessing treatment strategies for adults newly admitted to the intensive care unit
- Studying interventions used in urgent, high-acuity critical care
- Improving evidence for everyday decision-making in intensive care medicine
The focus is on practical evidence that can support better care for seriously ill patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 11 therapeutic areas and 15 of 29 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1HUS-yhtymae4active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1HUS-yhtymae4trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Central Finland Hospital District Central Finland Hospital Nova
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (20321) An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer sponsored studies | Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 29 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 2 | Unknown | 2024-05-31 | 2024-05-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
